QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company"), a company focused on advancing Additively Manufactured Electronics ("AME") for quantum computing infrastructure, today announced the ...

Noninvasive ventilation, cough-assist devices, and breathing exercises are among ways ALS patients can ease breathing issues. Early signs of weakening breathing function can be subtle. Patients should ...

ResMed CEO Mick Farrell is making a simple, powerful pitch to insurers and employers: every hour a patient uses a CPAP machine, up to seven ...

"If your heart stops, do you wish for life-prolonging measures?" Many people may have been puzzled when asked this by their ...

This article provides a comprehensive explanation of the pathological role of mucus plugs in asthma and chronic obstructive pulmonary disease (COPD), as well as evaluation methods using the latest ...

Background Dyspnoea is a prevalent, debilitating symptom in advanced life-limiting illnesses. While opioids and non-pharmacological measures remain foundational, refractory breathlessness presents a ...

Following the Philips V60 withdrawal, the SV70 offers respiratory departments a proven path forward built on clinical confidence and long-term standardization. The launch arrives at a pivotal moment ...

Mindray, a global leader in healthcare innovation across perioperative, medical imaging, and critical care, today announced the launch of the SV70 Non-Invasive Ventilator, the newest addition to the ...

A total of 205 women (76 infertility patients and 129 healthy controls) were enrolled between October 2025 and February 2026. Vaginal swabs were collected for 16S rRNA sequencing and Olink Target 96 ...

Noninvasive ventilation (NIV) is the recommended first-line respiratory support for acute heart failure (AHF)–related respiratory failure. However, its tolerance is often limited. High-flow nasal ...

Risk assignment should be repeated at every NMIBC occurrence/recurrence, with surveillance intervals tailored by risk group and upper-tract imaging every 1-2 years for intermediate/high-risk patients.